News Story: Full Text
Sponsored By
Gamma Tiles
Please Click On The Above Banner For More Details
Braintumor Website


New Phase 2 ICT-107 Vaccine trial opens in NJ!

Posted on: 01/21/2011

New Vaccine trial opens!

The long awaited phase 2 trial of the ICT-107 vaccine has now opened at JFK Medical Center in NJ.


The previous small phase 1 trial reported remarkable results:  80% Survival at 2 Years for newly diagnosed Glioblastoma Multiforme patients.  This compares very favorably to the historic controls reported of about 26.5%


Click HERE for details on this trial.




Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557